Planning to elope and marry in a temple? Now it's impossible in Mangaluru!

Chikkamagaluru, May 9: A young Hindu activist allegedly killed his brother at Beeranahalli in Tarikere taluk of Chikkamagaluru district in Karnataka over a board game dispute.

The accused has been identified as 26-year-old Kiran and the victim is his 29-year-old brother Arun, said police.

According to police, the duo were playing a board game on Thursday and they had placed a bet of Rs 500. 

After Arun won the game, he asked for the money and Kiran refused to yield, which lead to an argument. 

In a fit of rage, an intoxicated Kiran hit his brother and when the latter fell unconscious and dragged him on to the road.

Arun was immediately rushed to McGann Hospital in Shivamogga. However, he died on Thursday night, said police.

A case was registered at the Lakkavalli Police Station.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Mangaluru, Jul 4: In the wake of mounting coronavirus cases in Dakshina Kannada, all jewellery shops district will be closed for five days from July 5 to July 9.

The decision was taken by the Dakshina Kannada district unit of Jewellers’ Association.

All the jewellery shops including corporate jewellery shops in Manglauru and other parts of district will remain closed for five days, a media release said.